What is the Site Selection in Cell Therapy Trials course about?
Score your own function red, amber or green, find out which part is weakest, and walk into the next budget round able to defend what you want to fix. Built for leaders reviewing decide which trial sites to prioritize for rapid patient recruitment while maintaining regulatory compliance. Each order is checked and updated against the latest insights before delivery. That is why.
What does the Site Selection in Cell Therapy Trials cover on the situation this is built for?
Every day lost enrolling patients delays data readouts, investor milestones, and potential approvals. Yet selecting sites involves balancing complex variables: apheresis capacity, cell handling logistics, regulatory history, investigator engagement, and patient referral networks. Standard operating procedures from traditional trials don’t translate. You’re expected to decide where to invest millions, with incomplete data and high scrutiny. And when a site underperforms, the entire timeline.
Who is the Site Selection in Cell Therapy Trials course for?
Director of Clinical Operations in a cell therapy development organization, responsible for trial execution, site activation, and patient enrollment timelines.
Who is the Site Selection in Cell Therapy Trials course not for?
This is not for clinical research associates, data managers, or regulatory specialists focused only on submission strategy. It is for those who own site selection and enrollment execution.
What do you take away from the Site Selection in Cell Therapy Trials course?
Accelerate site activation with a validated assessment model Reduce enrollment delays due to poor site fit Standardize site evaluation across programs Improve audit readiness for site selection decisions Align cross-functional stakeholders on site prioritization.
How does this map to your situation?
Assessment of current site selection practices Framework development for capability scoring Forecasting and modeling enrollment dynamics Governance and continuous improvement systems.
What's included with your purchase?
12 modules with 12 chapters each (144 chapters) Downloadable templates and worked examples for every module Hand-built implementation playbook delivered alongside course access 30-day money-back guarantee.
What does the Site Selection in Cell Therapy Trials cover on delivery and format?
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access. Time investment: Approximately 8 to 10 hours of focused learning, plus 2 to 3 hours to adapt templates to your current program.
Closely related courses: Cell Therapy Commercialization, SOC 2 for Cell and Gene Therapy Operations Leaders.
More answers: what you get with every course, refund policy, all help answers.
Page updated 2026-11-06.
The Executive Diagnostic and Governance Toolkit
Mastering Site Selection in Cell Therapy Trials
Score your own function red, amber or green, find out which part is weakest, and walk into the next budget round able to defend what you want to fix. Built for leaders reviewing decide which trial sites to prioritize for rapid patient recruitment while maintaining regulatory compliance.
Each order is checked and updated against the latest insights before delivery. That is why access takes up to 24 hours rather than being instant.
| 1 |
You stop guessing where you stand. You finish with a score, not an opinion: every part of your function rated red, amber or green, with the weakest ranked first. Evidence: a Quick Scan for the shape of it, then seven domain assessments of 30 scored questions each, 210 in all, rolled into one scorecard, plus a maturity radar and a current-versus-target gap analysis. |
| 2 |
You can defend the decision. You walk into the budget round with the gap named, the owner named and done defined, instead of a case built on instinct. Evidence: project charter, scope statement, RACI, requirements traceability and work breakdown structure, pre-filled in your domain's language. |
| 3 |
The work actually moves. The month after the decision is already built, so nothing stalls waiting for someone to design a form. Evidence: more than 60 project templates across all five PMBOK process groups, plus runbooks, SOPs, a KPI framework, audit checklists and a risk matrix. 55 to 65 files in total. |
| 4 |
You use it the day it lands. No blank templates to interpret. Every workbook opens with what it is, who uses it, when, how, a 1 to 5 scoring guide, what good looks like, and a worked example you delete and type over. |
The situation this is built for
Every day lost enrolling patients delays data readouts, investor milestones, and potential approvals. Yet selecting sites involves balancing complex variables: apheresis capacity, cell handling logistics, regulatory history, investigator engagement, and patient referral networks. Standard operating procedures from traditional trials don’t translate. You’re expected to decide where to invest millions—with incomplete data and high scrutiny. And when a site underperforms, the entire timeline shifts.
Who this is for
Director of Clinical Operations in a cell therapy development organization, responsible for trial execution, site activation, and patient enrollment timelines.
Who this is not for
This is not for clinical research associates, data managers, or regulatory specialists focused only on submission strategy. It is for those who own site selection and enrollment execution.
What you walk away with
- Accelerate site activation with a validated assessment model
- Reduce enrollment delays due to poor site fit
- Standardize site evaluation across programs
- Improve audit readiness for site selection decisions
- Align cross-functional stakeholders on site prioritization
How this maps to your situation
- Assessment of current site selection practices
- Framework development for capability scoring
- Forecasting and modeling enrollment dynamics
- Governance and continuous improvement systems
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 8–10 hours of focused learning, plus 2–3 hours to adapt templates to your current program.
How this compares to the alternatives
Unlike generic clinical operations courses, this program focuses exclusively on the complexities of site selection in cell therapy—addressing apheresis integration, chain of identity, regulatory scrutiny, and patient logistics with field-specific tools and decision frameworks.
Also included: the full course, for when you want the reasoning behind a finding (12 modules, 144 chapters)
Depth reference. The diagnostic and the templates stand on their own; this is what to read when you want the reasoning behind a finding.
- Defining the scope of site selection responsibility
- Mapping the cell therapy trial site lifecycle
- Identifying critical differences from traditional trials
- Assessing the impact of apheresis logistics on site choice
- Recognizing regulatory scrutiny points in site evaluation
- Balancing speed and compliance in site prioritization
- Understanding the role of investigator expertise
- Evaluating site-specific patient referral networks
- Integrating supply chain constraints into site decisions
- Documenting rationale for audit-ready site selection
- Aligning site selection with clinical monitoring plans
- Measuring the cost of delayed site activation
- Designing a tiered site qualification checklist
- Incorporating cell processing timelines into site scoring
- Assessing cryopreservation and storage infrastructure
- Evaluating site experience with chain of identity protocols
- Scoring investigator commitment and bandwidth
- Validating local IRB and ethics committee responsiveness
- Mapping site proximity to apheresis centers
- Benchmarking against historical enrollment performance
- Integrating site financial stability into risk scoring
- Assessing language and consent process readiness
- Reviewing site experience with adverse event reporting
- Documenting site training capacity for complex protocols
- Identifying reliable sources of patient pool data
- Estimating referral rates from treating physicians
- Adjusting for disease prevalence in geographic regions
- Incorporating screening failure rates into forecasts
- Modeling the impact of comorbidities on eligibility
- Factoring in site staff turnover on enrollment pace
- Using historical activation timelines to predict delays
- Quantifying the effect of consent complexity on drop-off
- Projecting enrollment based on site staffing levels
- Adjusting for seasonal patient availability patterns
- Building confidence intervals into enrollment models
- Validating forecast assumptions with site visits
- Understanding GCP requirements for site qualification
- Documenting site selection rationale for inspectors
- Aligning site choices with country-specific regulations
- Evaluating site experience with regulatory audits
- Incorporating pharmacovigilance readiness into scoring
- Assessing site capability for source data verification
- Reviewing site history with regulatory findings
- Ensuring informed consent process meets jurisdictional rules
- Validating electronic data capture compliance
- Mapping site processes to chain of custody standards
- Preparing for unannounced regulatory visits
- Archiving site evaluation documentation appropriately
- Assessing apheresis center integration with trial sites
- Evaluating cold chain transport reliability by region
- Mapping cell product return timelines to sites
- Factoring in import and export permit lead times
- Assessing site capability for chain of identity tracking
- Validating temperature monitoring systems at site level
- Evaluating site staff training on handling procedures
- Integrating courier service coverage into site scoring
- Assessing backup plans for transport disruptions
- Reviewing site experience with product deviation reporting
- Aligning site operating hours with manufacturing schedule
- Documenting contingency plans for shipment delays
- Defining roles in the site selection committee
- Creating a cross-functional site evaluation meeting agenda
- Documenting dissenting opinions in selection records
- Setting thresholds for site approval and escalation
- Aligning medical affairs on investigator suitability
- Integrating regulatory input into site readiness checks
- Engaging supply chain on logistical feasibility
- Incorporating clinical monitoring perspectives
- Establishing criteria for site reevaluation
- Managing CRO recommendations within governance
- Tracking site selection decisions in a central log
- Conducting post-selection debriefs for continuous improvement
- Mapping the site activation critical path
- Identifying common bottlenecks in contract negotiation
- Streamlining ethics submission processes
- Accelerating site-specific training completion
- Reducing delays in insurance and indemnity setup
- Tracking IRB approval timelines by jurisdiction
- Optimizing site initiation visit scheduling
- Using parallel processing to compress timelines
- Anticipating language translation requirements
- Monitoring site document collection progress
- Establishing escalation paths for stalled sites
- Measuring activation velocity across programs
- Linking site selection data to monitoring frequency
- Identifying high-risk sites based on operational gaps
- Tailoring monitoring visit schedules to site maturity
- Incorporating remote monitoring into site oversight
- Using site performance data to adjust monitoring plans
- Assessing source data verification needs by site
- Evaluating site adherence to chain of identity
- Documenting monitoring rationale for auditors
- Integrating risk indicators into monitoring reports
- Training monitors on site-specific protocol challenges
- Establishing triggers for increased monitoring intensity
- Reviewing monitoring strategy at program milestones
- Evaluating site experience with electronic data capture
- Assessing source document organization practices
- Reviewing site compliance with data retention policies
- Validating date and time stamping procedures
- Ensuring witness requirements for critical entries
- Auditing site adherence to data correction policies
- Integrating data quality metrics into site scoring
- Assessing backup and recovery procedures for records
- Training site staff on data entry timelines
- Monitoring for patterns of late data entry
- Documenting data management training completion
- Preparing sites for source data verification audits
- Assessing site support for patient travel logistics
- Evaluating accommodations for international patients
- Reviewing language concordance between staff and patients
- Integrating patient advocacy group feedback
- Assessing site experience with patient-reported outcomes
- Measuring patient satisfaction from prior trials
- Designing site workflows to minimize patient burden
- Evaluating caregiver support infrastructure
- Assessing follow-up visit scheduling flexibility
- Integrating patient feedback into site selection
- Documenting patient retention strategies at site level
- Tracking patient dropout reasons across sites
- Defining key performance indicators for site activity
- Setting thresholds for underperformance intervention
- Collecting real-time enrollment data by site
- Analyzing screening failure root causes per site
- Conducting regular site performance review meetings
- Documenting rationale for site discontinuation
- Evaluating site responsiveness to corrective actions
- Assessing protocol deviation rates across sites
- Measuring data query resolution timelines
- Tracking site communication responsiveness
- Reviewing site monitoring visit findings trend
- Updating site risk profiles based on performance
- Building a centralized site qualification database
- Standardizing site assessment templates across studies
- Incorporating lessons from past trials into new models
- Creating a site performance memory system
- Establishing site tiering by therapeutic area
- Developing site pre-qualification processes
- Sharing site insights across development programs
- Training new staff on institutional site selection norms
- Integrating site feedback into protocol design
- Automating data collection for site scoring
- Benchmarking site performance across indications
- Measuring the ROI of site selection improvements
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
Thousands of organisations have bought from The Art of Service since 2000.